logo
UK ‘long overdue' a conversation about NHS funding, says Javid

UK ‘long overdue' a conversation about NHS funding, says Javid

Western Telegraph16 hours ago
Sir Sajid, also a former health secretary, said the country 'cannot afford' to 'bury our heads in the sand' when it comes to how the UK pays for healthcare.
His comments are part of the foreword for the PolicyExchange's report The NHS – A Suitable Case For Treatment.
The centre-right thinktank suggests that 'better quality healthcare' could be delivered 'by moving from our present entirely socialised model to a hybrid model with a significant social insurance component'.
They also advocate changes such as removing free prescriptions for over-60s, but the report says that 'under no circumstances' should the UK try to replicate the US model of healthcare.
Introducing the paper, Sir Sajid described the NHS as 'one of our country's most treasured and beloved national institutions'.
'We've come to a crossroads. A serious conversation with taxpayers about how we continue funding their favourite national institution is long overdue,' he said.
He said that the UK is left with the options of putting more money into healthcare through tax rises or 'reforming' the system.
Sir Sajid said 'we cannot afford to do is to bury our heads in the sand' (Aaron Chown/PA)
'What we cannot afford to do is to bury our heads in the sand,' he added.
'The responsible politician, the one who is concerned with the national interest, must look at every option for reform,' Sir Sajid said.
The PolicyExchange report says that 'under no circumstances should the UK consider moving towards the US model', but that other countries 'with some sort of insurance-based model do much better' such as France, Germany and Singapore.
'We believe that better quality healthcare with universal coverage and improved long-term funding sustainability could be secured by moving from our present entirely socialised model to a hybrid model with a significant social insurance component,' the report says.
Alongside a shift towards a 'social-insurance based system of financing healthcare', the thinktank made a number of recommendations for reforms that could be made within the existing NHS model.
Among the changes the PolicyExchange suggest are a £20 charge for visiting a GP, with low-income groups exempt.
They also say that people over 60 should no longer be universally eligible for free prescriptions, and the exemption should be determined by your income.
They also advocate charges for 'more luxurious hospital accommodation', which they say could raise £700million.
PolicyExchange advocate a system where universal healthcare coverage is available, and a basic model can be supplemented by other policies.
The Government would regulate insurers and healthcare providers, and they say the system should still be called the NHS, with the main change being the way it is financed.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Sky News star ‘fell through the gaps' with stage four cancer diagnosis
Sky News star ‘fell through the gaps' with stage four cancer diagnosis

Daily Mirror

time28 minutes ago

  • Daily Mirror

Sky News star ‘fell through the gaps' with stage four cancer diagnosis

Journalist Dermot Murnaghan shared his stage four prostate cancer diagnosis and has urged other men to get PSA tests while also highlighting new treatment hopes Former Sky News presenter Dermot Murnaghan has revealed how he 'fell through the gaps' in his healthcare after being diagnosed with stage four prostate cancer, calling his diagnosis a serious 'wake-up call.' ‌ The 67-year-old announced his condition in June and has since been advocating for greater awareness about the importance of testing. Speaking at an event for Prostate Cancer UK, Murnaghan shared the story behind his diagnosis and urged men to be proactive about their health. ‌ He admitted: 'For years I thought 'that will do me' - I'm getting tested basically once a year or every couple of years.' However, he soon realised that the tests he was undergoing privately didn't include screening for PSA (prostate-specific antigen), which is crucial for early detection of prostate cancer. ‌ 'It never occurred to me that they weren't testing for PSA, and I never went to my GP because I was getting other tests privately through the production company,' he explained. 'So that's how I fell through the gaps and that's how I had a massive wake-up call and want to share the message.' Prostate cancer can progress silently without any symptoms. Stage four, which is the most advanced stage, means the cancer has spread beyond the prostate, potentially affecting other organs such as the bladder, bones, lungs, or liver. ‌ Despite its prevalence, affecting about one in eight men in their lifetime, there is currently no routine national screening programme for prostate cancer. The PSA blood test is available but not routinely recommended by the NHS due to concerns about its accuracy. Men over 50 can request the test from their GP. Murnaghan has now emphasised the importance of insisting on testing, regardless of symptoms or age. 'You can get to the stage I have with no symptoms. Get the test, insist on the test,' he said. ‌ 'You can insist on the test if you are in a high-risk group and under 50. If you are not, I'd still get the test at 50. Go to your GP and they say you don't need it but say 'but I want it'. It is your right to have it. Just keep doing that every year or couple of years.' He also encouraged men to regularly monitor their PSA levels. 'Once you've got that marker where your PSA is, keep monitoring it,' Murnaghan said. 'The earlier you find prostate cancer the easier it is to treat. Check your risk in just 30 seconds with Prostate Cancer UK's online risk checker to see if you are at risk and what you can choose to do about it.' On treatment, Murnaghan expressed his optimism about new developments as he said: 'In terms of the treatments for the stage I'm at, they are a myriad. What's astonishing is just how fast things are developing." ‌ The former Sky News reporter revealed that the treatment he's receiving was only approved within the last few years. 'There is a lot of hope out there, there's a lot going on, there's a lot of advice and a lot of things happening. As a sufferer and a non-medical person, my advice is ask questions. There are always different ways of doing things… keep asking those questions about where you are and what's available.' Murnaghan also announced he will take part in Tour de 4, a charity cycling event led by Sir Chris Hoy to raise funds and awareness for cancer charities across the UK. ‌ The Olympian revealed his own terminal prostate cancer diagnosis in October 2024. 'I'm really proud to be supporting Prostate Cancer UK and taking part in Sir Chris Hoy's fundraising event, the Tour de 4,' Murnaghan said. 'This groundbreaking cycling challenge is raising vital funds and changing the conversation. I'll be riding in Glasgow this September alongside some incredible participants, all to raise awareness and help save men's lives. Prostate Cancer UK means a lot to me and I'd love for you to get involved and show your support. Together we can make a real difference." The Macmillan Support Line offers confidential support to people living with cancer and their loved ones. If you need to talk, call them on 0808 808 0000.

Dermot Murnaghan ‘fell through the gaps' with stage four cancer diagnosis
Dermot Murnaghan ‘fell through the gaps' with stage four cancer diagnosis

Rhyl Journal

time31 minutes ago

  • Rhyl Journal

Dermot Murnaghan ‘fell through the gaps' with stage four cancer diagnosis

The broadcaster, 67, announced his diagnosis with stage four prostate cancer in June, saying he was 'responding positively' to treatment. Speaking at an event for Prostate Cancer UK, the broadcaster shared his diagnosis journey and urged men to get tested. He said: 'For years I thought 'that will do me' I'm getting tested basically once a year or every couple of years. 'It never occurred to me that they weren't testing for PSA (prostate-specific antigen) and I never went to my GP because I was getting other tests privately through the production company. 'So that's how I fell through the gaps and that's how I had a massive wake-up call and want to share the message.' Stage four prostate cancer can mean that the cancer has spread into different parts of the body including nearby body organs, such as the back passage or bladder, and other parts of the body outside the pelvis, such as the bones, lungs or liver, according to the Cancer Research UK website. About one in eight men will get prostate cancer in their lifetime, according to the charity Prostate Cancer UK, however, there currently are no screening programmes for men to get tested. One option is a PSA blood test which checks the level of prostate-specific antigens in the blood. A high reading may be a sign of a prostate condition. NHS guidance says these tests are not routinely used as they are not reliable, but men over 50 can ask GPs for one. Murnaghan added: 'You can get to the stage I have with no symptoms. 'Get the test, insist on the test. You can insist on the test if you are in a high-risk group and under 50. If you are not, I'd still get the test at 50. 'Go to your GP and they say you don't need it but say 'but I want it'. It is your right to have it. Just keep doing that every year or couple of years. Once you've got that marker where your PSA is, keep monitoring it. 'The earlier you find prostate cancer the easier it is to treat, so check your risk in just 30 seconds with Prostate Cancer UK's online risk checker to see if you are at risk and what you can choose to do about it.' The presenter also shared an update on his treatment, adding that 'there is a lot of hope' with new trials and options available. He said: 'In terms of the treatments for the stage I'm at, they are a myriad. What's astonishing is just how fast things are developing, even at last stage advanced prostate cancer, the treatment I'm on, the programme that I've been getting only really was approved within the last couple of years. 'There is a lot of hope out there, there's a lot going on, there's a lot of advice and a lot of things happening there. So as a sufferer and a non-medical person my advice is, ask questions. There are always different ways of doing things, slightly, but just keep asking those questions about where you are, what there is available or even if perhaps you could access one of those clinical trials yourself.' The broadcaster will join Sir Chris Hoy's fundraising charity bike ride, Tour de 4, to raise awareness and funds for chancer charities across the UK. The Olympian announced he had a terminal diagnosis for prostate cancer in October 2024. Murnaghan added: 'I'm really proud to be supporting Prostate Cancer UK and taking part in Sir Chris Hoy's fundraising event, the Tour de 4. This groundbreaking cycling challenge is raising vital funds for cancer charities and changing the conversation. 'I'll be riding in Glasgow this September alongside some incredible participants, all to raise awareness and help save men's lives. Prostate Cancer UK means a lot to me and I'd love for you to get involved and show your support. Together we can make a real difference.'

Why the UK is lagging behind other countries on measles vaccinations
Why the UK is lagging behind other countries on measles vaccinations

The Independent

time36 minutes ago

  • The Independent

Why the UK is lagging behind other countries on measles vaccinations

The UK is the worst-performing G7 country for coverage of measles vaccines, as rates lag behind Europe, with experts warning declining health budgets and the spread of misinformation are putting children at risk. Now, health officials in the UK have sounded the alarm over our waning vaccine coverage after a child with measles died in Liverpool. On Monday, health secretary Wes Streeting said that the child's death shows the nation needs to 'redouble its efforts' to vaccinate more children and said improvements promised in the NHS's 10-year plan, such as giving parents access to digital health records, could help. One expert told The Independent a multitude of issues have impacted the UK's measles vaccination rates, including declining public health budgets, lower access to GP services, and the increased circulation of misinformation on social media. How does the UK compare to other G7 countries? Data published by the World Health Organisation (WHO) and the charity UNICEF estimates the UK has just 89 per cent coverage of the first measles vaccine in 2024 and 85 per cent coverage of the second dose. This is down from 93 per cent a decade earlier and well below WHO target of 95 per cent, which it said is needed to effectively eliminate the spread of the disease in the community. And we're lagging well behind our G& counterparts, with vaccine rates in Germany the highest (96 per cent), Italy and France (95 per cent) and Japan (94 per cent)/. The organisations warned that the global rates of childhood vaccinations are falling, with 30 million children unvaccinated. Rates of the first MMR vaccine across the UK have been in decline since 2014. An analysis by the Nuffield Trust of 2023-24 data shows England lags behind Wales, Scotland and Northern Ireland on coverage of this vaccine. Within England, London has the worst coverage by far, with just 81 per cent of children having received a first course by their second birthday. Data as of June 2025 shows that the capital accounted for 44 per cent of all measles cases. Measles is a highly contagious, serious airborne disease caused by a virus that can lead to severe complications and death. Dr Connor Bamford, Virologist, Queen's University Belfast, explained: 'Various conditions can make individuals more vulnerable to severe measles. This may include immunosuppressed individuals undergoing cancer treatment for example who, because of their condition, have lost immunity to the virus, even if they have been vaccinated." He said: "We do see children and adults dying from measles in the UK and the last young person who died was reported in 2024. In 2023, we saw another child die of a disease called SSPE (subacute sclerosing panencephalitis), which is a fatal complication of measles that occurs years after an earlier infection. In 2023 two adults also died." In the UK, immunisation against it is typically given as part of the MMR vaccine for measles, mumps and rubella. According to the NHS, around 99 per cent of people who receive the MMR vaccine will be protected against measles and rubella. Meanwhile, around 88 per cent will be protected against mumps, and anyone who does get it after vaccination will experience milder symptoms. What has impacted vaccine uptake in the UK? According to the Nuffield Trust, uptake of the MMR vaccine decreased significantly following a now discredited article by Dr Andrew Wakefield in 1998, which linked MMR vaccination to autism. By 2003-04 uptake of the vaccine had dropped to 80 per cent. However, coverage then improved and hit 93 per cent in 2013-14, before dropping again to 89 per cent in 2023-24. A recent survey by the UK Health Security Agency (UKHSA) suggested that overall, parents in the UK have a high level of confidence that vaccines work for children, with 87 per cent of those surveyed having agreed with this. However, vaccine coverage for MMR and other key childhood vaccines has declined in recent years, and now health officials are urging parents to get their children vaccinated. Speaking with The Independent, Adam Finn, Professor of Paediatrics at the University of Bristol, and a member of the government's Joint Vaccinations and Immunisations Committee, explained there were several factors, including the fact that there has been a general decline in immunisation over the past 15 years, which had initially been ignored. He said: 'The public health authority officials favour the idea that it's because there's been a waning of resource in the health service to deliver the vaccine programme, so as primary care in particular has become more stretched the capacity to chase people up and go after the people that are otherwise not getting their act together has disappeared and that's resulted in the vulnerable edge getting worse and worse.' 'The competing hypothesis, which is quite convenient for the politicians, is that it's mad internet misinformation, and in a sense, people are somehow to blame for believing it and that it's not really a governmental problem, it's myth and legend, as it were.' 'My view is that those two things are not mutually exclusive.' He said while there are a group of parents and people who avoid vaccination, there are another group who don't do it because they're not aware, or it's not high up on their priority list. The professor of paediatrics also suggested that vaccines, such as MMR, were a victim of their own success, with the public no longer having a living memory of the severe and life-threatening impacts of the disease. In the 1960s, people would've queued around the block to get their children immunised because they were afraid of them dying of those diseases where whereas now they've never heard of them, he said. Possible solutions? One key solution is enabling healthcare workers, such as GPs or health visitors, to have conversations around vaccines with parents, says Professor Finn. 'The government has come in with a mission to solve the problem of the under-resourced health service and has emphasised the way it wants to do that is to stop people from getting ill rather than build more hospitals. 'And one of the most obvious and effective, proven and countable ways of doing that is to ensure vaccine programmes are delivered, and so I think it should be a fairly open and closed argument that this is where Wes Streeting needs to put his money.' Where access to GPs and health visitors is an issue, experts have suggested expanding the list of places where parents can get vaccines, and information about them could help. Malcolm Harrison, Chief Executive of the Company Chemists' Association (CCA), has suggested pharmacies could assist. He said last year, a pilot in the North West of England allowed children aged 5 to 11 who had missed doses to get the MMR vaccine at their local pharmacy for the first time. Experts have also suggested that schools could be an important place for children's vaccines to be accessed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store